Clinical Trial Update: A Study of Guselkumab in Participants With Active Psoriatic Arthritis [Phase 3]

View source ↗

Summary

Guselkumab is being studied in a Phase 3 trial for active psoriatic arthritis. The study is currently active but not recruiting, and results were posted on 2026…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• TREMFYA (guselkumab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Arthritis, Psoriatic | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2026-02-04